Positive trial results for Eli Lilly’s Donanemab in Alzheimer’s
A positive Phase 2 Trial of Eli Lilly’s donanemab, an investigational antibody, has shown significant slowing of decline in a composite measure of cognition...
New transatlantic cancer research partnership
The two largest funders of cancer research in the world are set to make radical progress against cancer with a new scientific cancer research...
How pharma can enhance its digital presence
With COVID-19 accelerating online migration this year, the pharma industry has had to embrace online - and fast. Traditionally reliant on face-to-face communication and...
Career advice from pharma professionals
In an industry which has excelled in the face of adversity this year, some expert advice can help you do the same in your...
Changes to the landscape of commercial recruitment
As Covid-19 continues to shift and shape the landscape of commercial recruitment, Pf talks with Andy Anderson at Evolve about its impact going forward. How...
Why candidates need to be omnichannel ready
Judy Phillips from Chase looks at how working practices are changing and why it is important that candidates in 2020 are omnichannel ready. COVID-19 and...
Interview with Pf Awards Future Leader winner
In this interview, Pf Awards Future Leader winner, Lauren Laskier, reflects on her accolade and how the recognition has pushed her forward in her...
Surviving redundancy
Clare Hill, Owner of Smart Culture Psychology, looks at how, as furlough comes to an end and companies review their workforces, redundancies are inevitable....
Reflections on regulatory information management in 2020
What has COVID-19 revealed in the way of regulatory information management (RIM) related shortcomings, and to what extent should pharmaceutical companies step up their...
How the NHS and pharma are working together to improve cancer...
Despite a difficult year for cancer services, cancer survival rates are improving in the UK, and it is vital that all parts of the...
